RNA interference by nanofiber-based siRNA delivery system

被引:111
|
作者
Cao, Haoqing [1 ]
Jiang, Xu [1 ]
Chai, Chou [2 ]
Chew, Sing Yian [1 ]
机构
[1] Nanyang Technol Univ, Div Chem & Biomol Engn, Sch Chem & Biomed Engn, Singapore 637459, Singapore
[2] Duke NUS Grad Med School, Singapore 169857, Singapore
关键词
SiRNA; Nanofibrous scaffolds; Scaffold-mediated transfection; Electrospinning; Tissue engineering; IN-VIVO DELIVERY; CONTROLLED-RELEASE; POLYMER NANOFIBERS; MOLECULAR-WEIGHT; DNA DELIVERY; CELLS; GENE; PROTEIN; SCAFFOLDS; FIBERS;
D O I
10.1016/j.jconrel.2010.02.003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
SiRNA delivery has found useful applications particularly as therapeutic agents against genetic diseases. Currently, the delivery of siRNA typically takes the form of nanoparticles. In order to expand the applications of these potent but labile molecules for long-term use required by tissue engineering and regenerative medicine, alternative delivery vehicles are required. This work presents a scaffold-mediated approach to siRNA delivery. By encapsulating siRNA within polycaprolactone (PCL) nanofibers (300-400 nm in diameter) controlled release of intact siRNA could be achieved for at least 28 days under physiological conditions. The successful transfection of HEK 293 cells with GAPDH siRNA released from fibrous scaffolds at day 5, 15 and 30 demonstrated that the encapsulated molecules remained bioactive throughout the period of sustained release, providing silencing efficiency of 61-81% that was comparable to conventional siRNA transfection. Direct seeding of cells on these biofunctional scaffolds, with and without transfection reagent, demonstrated enhanced cellular uptake and efficient GAPDH gene-silencing. This work demonstrates the potential of nanofibrous scaffold-mediated siRNA delivery for long-term gene-silencing applications. The combination of topographical features provided by nanofibrous scaffolds may provide synergistic contact guidance and biochemical signals to mediate and support cellular development in regenerative medicine. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:203 / 212
页数:10
相关论文
共 50 条
  • [1] Nanofiber-based Drug Design, Delivery and Application
    Lv, Yonggang
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (15) : 1918 - 1919
  • [2] Nanofiber-Based Delivery of Therapeutic Peptides to the Brain
    Mazza, Mariarosa
    Notman, Rebecca
    Anwar, Jamshed
    Rodger, Alison
    Hicks, Matthew
    Parkinson, Gary
    McCarthy, Dave
    Daviter, Tina
    Moger, Julian
    Garrett, Natalie
    Mead, Tania
    Briggs, Michael
    Schaetzlein, Andreas G.
    Uchegbu, Ijeoma F.
    ACS NANO, 2013, 7 (02) : 1016 - 1026
  • [3] RNA interference induced by the cationic lipid delivery of siRNA
    Bouxsein, NF
    McAllister, CS
    Ewert, K
    Samuel, CE
    Safinya, CR
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 420A - 420A
  • [4] Electrospun Nanofiber-Based Patches for the Delivery of Cardiac Progenitor Cells
    Streeter, Benjamin W.
    Xue, Jiajia
    Xia, Younan
    Davis, Michael E.
    ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (20) : 18242 - 18253
  • [5] Nanofiber-based Aerogels
    Burger, T.
    Deuber, F.
    Merk, M.
    Mousavi, S.
    Vejsadova, L.
    Adlhart, C.
    CHIMIA, 2017, 71 (05) : 311 - 311
  • [6] RNA interference in immune cells by use of osmotic delivery of siRNA
    Aoki, M
    Ishii, T
    Kanaoka, M
    Kimura, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (02) : 326 - 333
  • [7] Impact of delivery systems on siRNA immune activation and RNA interference
    Forsbach, Alexandra
    Mueller, Christian
    Montino, Carmen
    Kritzler, Andrea
    Curdt, Rainer
    Benahmed, Amina
    Jurk, Marion
    Vollmer, Joerg
    IMMUNOLOGY LETTERS, 2012, 141 (02) : 169 - 180
  • [8] Nanofiber-based Delivery of Luliconazole: Fabrication, Characterization, and Therapeutic Performance Assessment
    Nimhan, Gauri
    Narwade, Mahaveer
    Jadon, Rajesh Singh
    Gajbhiye, Kavita
    AAPS PHARMSCITECH, 2024, 25 (05)
  • [9] Nanofiber-based delivery of bioactive agents and stem cells to bone sites
    Zhang, Zhanpeng
    Hu, Jiang
    Ma, Peter X.
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (12) : 1129 - 1141
  • [10] PEG-PEI/siRNA and PEI/siRNA complexes for siRNA delivery to induce RNA interference (RNAi)
    Malek, A.
    Merkel, O.
    Czubayko, F.
    Kissel, T.
    Aigner, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 70 - 70